Single Vaccine Protects Against Three Deadly Strains of Coronavirus
A vaccine designed to protect against three different deadly coronaviruses shows success in mouse studies, demonstrating the viability of a pan-coronavirus vaccine developed by researchers at the D
School of Medicine Celebrates 2023 Faculty Award Recipients
Duke University School of Medicine acknowledge faculty members who were selected as recipients of this year’s School of Medicine faculty awards.
Duke Health Leads Its First Clinical Trial Testing a New Universal Flu Vaccine
Duke Health is leading its first clinical trial under a large federal initiative to develop a new-generation flu vaccine.
Protection Against Future Variants: Developing the Pan-Coronavirus Vaccine
When the COVID-19 pandemic began in 2020, faculty members in Duke Surgery’s Division of Surgical Sciences quickly joined the efforts to develop a vaccine against SARS-CoV-2.
Gift Honors Decades-Long Collaboration of Renowned Researchers
A $6.6M endowed gift by Marion Stein, MD, in memory of her late husband, Norm Letvin, MD, & in honor of Bart Haynes, MD, will significantly advance new vaccine development + therapies for HIV/A
Duke Human Vaccine Institute Wins Contract to Produce Pan-Coronavirus Vaccine
The Duke Human Vaccine Institute has received a federal contract to manufacture a pan-coronavirus vaccine candidate that can be tested in a phase 1 clinical trial.